Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,371.84
(
-0.49%
)
US TECH 100
28,065.20
(
-1.03%
)
Dow Jones
49,553.41
(
0.06%
)
Brent Oil
107.80
(
0.31%
)
Bitcoin
76,367.01
(
-1.35%
)
News Focus
News Focus
Post# of 257581
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jq1234 post# 172873

Friday, 02/14/2014 10:01:16 AM

Friday, February 14, 2014 10:01:16 AM

Post# of 257581
FDA rescinds REMS requirement for Xarelto while also rejecting sNDA for ACS:

http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/202439Orig1s012ltr.pdf

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up